📊 Score Breakdown
Offering Ability
60
Cash Runway
40
Float Risk
45
Warrant Exposure
90
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
58%
📜 Warrant Exercise
60%
• Massive warrant overhang: 135% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion
60%
• Major convertible overhang: 49% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration
50%
• Score rose 53 points recently (worsening)
• Score in HIGH risk zone (75/100)
💹 Market Data
Market Cap$5.23M
Shares Outstanding4.02M
Float3.17M
Cash$6.95M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
7 institutional holders · 26.9K shares
#1
Clear Street Group Inc.
17.0K shares
#2
Bank of America Corporation
3.5K shares
#3
Barclays Plc
2.4K shares
+ 4 more holders Sign up free to view →
📉 Short Interest
Short Interest114.6K
Days to Cover2.2
% of Float3.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2022
Form 4
INSIDER TRANSACTION
Feb 17, 2026
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for DRMA
📊 DRMA FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 DRMA Signal Convergence & Dark Pool Activity — StonkWhisper
📄 DRMA Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.